• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsCALIWAY BIOPHARMACEUTICALS
    Picture of CALIWAY BIOPHARMACEUTICALS logo

    6919 — CALIWAY BIOPHARMACEUTICALS Share News

    TWD64.000.000.00%
    tw flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    • Market Cap
      TWD99.60bn
    • Enterprise Value
      TWD95.66bn
    • Revenue
      TWD38.04m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 6919 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    6919 Dividends
    • Brief: Caliway: New Drug CBL-514 Phase II Clinical Results' Demonstrated Efficacy

      21/09/2026 11:11
    • Brief: Caliway Says A Phase 2B Study For Reducing Abdominal Subcutaneous Fat Met All Main Goals

      11/12/2024 14:56
    • Brief: Caliway Announced EMA Orphan Drug Designation Granted To CBL-514 For Dercum's Disease Treatment

      12/11/2024 13:33
    • Brief: Caliway Biopharmaceuticals Expects IND Approvals For Cbl-514

      23/10/2024 17:02

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.